Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$370,565,128
+$184,582,116 QoQ
Shares Held
308,951
+52.8% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#186
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$599,715
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. LLY ranks #2 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
607,026 | $34,976,838 |
All Filings in LLY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,565,128 | 308,951 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $599,715 | 500 | Put | Sole | 2026-08-13 | |
| 2026-03-31 | $1,471,632 | 1,600 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $183,954 | 200 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $185,983,012 | 202,206 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $178,170,139 | 165,789 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $128,452,576 | 168,352 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $133,557,654 | 171,331 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $143,667,870 | 173,951 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $155,556,456 | 201,498 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $190,068,681 | 214,539 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $237,452,201 | 262,268 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $465,868,898 | 598,834 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $178,247,609 | 305,784 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $165,548,837 | 308,210 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $141,864,574 | 302,496 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $127,209,979 | 370,421 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $135,587,986 | 370,621 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $112,547,464 | 348,067 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $115,355,846 | 355,784 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $89,853,742 | 313,768 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $77,330,827 | 279,961 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $61,995,104 | 268,319 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $53,618,167 | 233,610 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,277,344 | 76,423 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $11,872,997 | 70,321 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,138,861 | 136,055 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $21,961,373 | 133,764 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,795,630 | 113,867 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||